BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14705204)

  • 1. Biodegradable nanoparticles containing protein-fatty acid complexes for oral delivery of salmon calcitonin.
    Sang Yoo H; Gwan Park T
    J Pharm Sci; 2004 Feb; 93(2):488-95. PubMed ID: 14705204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and in vitro-in vivo evaluation of salmon calcitonin-loaded polymeric nanoparticles.
    Glowka E; Sapin-Minet A; Leroy P; Lulek J; Maincent P
    J Microencapsul; 2010; 27(1):25-36. PubMed ID: 19229671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salmon calcitonin-loaded Eudragit® and Eudragit®-PLGA nanoparticles: in vitro and in vivo evaluation.
    Cetin M; Aktas MS; Vural I; Ozturk M
    J Microencapsul; 2012; 29(2):156-66. PubMed ID: 22126314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts.
    Song KH; Chung SJ; Shim CK
    J Control Release; 2005 Sep; 106(3):298-308. PubMed ID: 15979756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery.
    Garcia-Fuentes M; Prego C; Torres D; Alonso MJ
    Eur J Pharm Sci; 2005 May; 25(1):133-43. PubMed ID: 15854809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of polyion complex micelles to enhance the oral delivery of salmon calcitonin and transport mechanism across the intestinal epithelial barrier.
    Li N; Li XR; Zhou YX; Li WJ; Zhao Y; Ma SJ; Li JW; Gao YJ; Liu Y; Wang XL; Yin DD
    Biomaterials; 2012 Dec; 33(34):8881-92. PubMed ID: 22975427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of oral bioavailability of salmon calcitonin through chitosan-modified, dual drug-loaded nanoparticles.
    Liu L; Yang H; Lou Y; Wu JY; Miao J; Lu XY; Gao JQ
    Int J Pharm; 2019 Feb; 557():170-177. PubMed ID: 30597264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucoadhesive intestinal devices for oral delivery of salmon calcitonin.
    Gupta V; Hwang BH; Lee J; Anselmo AC; Doshi N; Mitragotri S
    J Control Release; 2013 Dec; 172(3):753-62. PubMed ID: 24035976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orally delivered salmon calcitonin-loaded solid lipid nanoparticles prepared by micelle-double emulsion method via the combined use of different solid lipids.
    Chen C; Fan T; Jin Y; Zhou Z; Yang Y; Zhu X; Zhang ZR; Zhang Q; Huang Y
    Nanomedicine (Lond); 2013 Jul; 8(7):1085-100. PubMed ID: 23075315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the antiresorptive activity of salmon calcitonin microspheres using cultured osteoclastic cells.
    Dani BA; Raiche AT; Puleo DA; DeLuca PP
    AAPS PharmSciTech; 2002; 3(3):E21. PubMed ID: 12916936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.
    Win KY; Feng SS
    Biomaterials; 2005 May; 26(15):2713-22. PubMed ID: 15585275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, characterization, and in vivo evaluation of salmon calcitonin microspheres.
    Dani BA; DeLuca PP
    AAPS PharmSciTech; 2001 Oct; 2(4):22. PubMed ID: 14727859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional permeability of salmon calcitonin in isolated rat gastrointestinal tracts: transport mechanism using Caco-2 cell monolayer.
    Shah RB; Khan MA
    AAPS J; 2004 Oct; 6(4):e31. PubMed ID: 15760096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and Characterizations of Inhalable Poly(lactic-
    Sato H; Tabata A; Moritani T; Morinaga T; Mizumoto T; Seto Y; Onoue S
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32183032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PHEA-graft-polymethacrylate supramolecular aggregates for protein oral delivery.
    Licciardi M; Pasut G; Amato G; Scialabba C; Mero A; Montopoli M; Cavallaro G; Schiavon O; Giammona G
    Eur J Pharm Biopharm; 2013 May; 84(1):21-8. PubMed ID: 23275110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of salmon calcitonin (sCT) enteric-coated capsule for enhanced absorption and GI tolerability in rats.
    Wu L; Zhang G; Lu Q; Sun Q; Wang M; Li N; Gao Z; Sun Y; Li T; Han D; Yu X; Wang L; Sun W; Zhao D; Wu Y; Lu Y; Chen X
    Drug Dev Ind Pharm; 2010 Mar; 36(3):362-70. PubMed ID: 19719396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flash Fabrication of Orally Targeted Nanocomplexes for Improved Transport of Salmon Calcitonin across the Intestine.
    Sun L; Le Z; He S; Liu J; Liu L; Leong KW; Mao HQ; Liu Z; Chen Y
    Mol Pharm; 2020 Mar; 17(3):757-768. PubMed ID: 32011888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and evaluation of poly(DL-lactic-co-glycolic acid) nanocomposite particles containing salmon calcitonin for inhalation.
    Yang M; Yamamoto H; Kurashima H; Takeuchi H; Yokoyama T; Tsujimoto H; Kawashima Y
    Eur J Pharm Sci; 2012 Aug; 46(5):374-80. PubMed ID: 22414702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adsorption of salmon calcitonin to PLGA microspheres.
    Calis S; Jeyanthi R; Tsai T; Mehta RC; DeLuca PP
    Pharm Res; 1995 Jul; 12(7):1072-6. PubMed ID: 7494805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticles.
    Samstein RM; Perica K; Balderrama F; Look M; Fahmy TM
    Biomaterials; 2008 Feb; 29(6):703-8. PubMed ID: 18006053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.